Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Turin, Italy.
Department of Drug Science and Technology, University of Turin, Italy.
Nutr Metab Cardiovasc Dis. 2019 Dec;29(12):1316-1322. doi: 10.1016/j.numecd.2019.07.009. Epub 2019 Jul 19.
The strategic role of prevention in hypertension setting is well known but, with the only exception of annually events promoted by international scientific societies, no other screening campaigns are available. Aim of this study was to assess the feasibility of a non-physician pharmacy-based screening program and to describe the cardiovascular risk and the BP status of participating subjects.
2731 costumers participated to the screening program, answering to a questionnaire about personal cardiovascular risk and measuring their BP with an Omron HEM 1040-E. Since no threshold for hypertension diagnosis is currently available for community pharmacies BP measurements, we assessed high BP prevalence according to 3 different cut-offs (≥140/90, ≥135/85 and ≥ 130/80 mmHg) and compared normotensives and hypertensives on major cardiovascular risk factors. According to the proposed cut-offs, prevalence of hypertension was respectively of 31%, 45% and 59.5%, and it increased among younger subjects (31-65 y) when the lowest cut-offs were applied. High BP was found in a large percentage of subjects self-declared on-/not on-treatment (uncontrolled hypertensives) or normotensives (presumptive hypertensives) and among those not aware of their own BP values (presumptive hypertensives). Prevalence of CV risk factors was higher in hypertensives than in normotensives.
Our findings demonstrated that a community pharmacy-based screening is feasible and attracts the interests of many subjects, improving awareness on their BP status. The screening was also showed to be useful in order to detect potentially uncontrolled and/or suspected new hypertensives, especially among young adults, to refer to general practitioners for confirmatory diagnosis or further evaluation.
预防在高血压环境中的战略作用是众所周知的，但除了国际科学协会每年举办的活动外，没有其他的筛查活动。本研究旨在评估一个非医师药剂师为基础的筛查计划的可行性，并描述参与研究的受试者的心血管风险和血压状况。
2731 名顾客参加了筛查计划，回答了一份关于个人心血管风险的问卷，并使用欧姆龙 HEM 1040-E 测量了他们的血压。由于目前社区药房的血压测量值没有高血压诊断的阈值，我们根据 3 个不同的截止值（≥140/90、≥135/85 和≥130/80mmHg）评估了高血压的患病率，并比较了正常血压者和高血压者的主要心血管危险因素。根据提出的截止值，高血压的患病率分别为 31%、45%和 59.5%，并且在应用最低截止值时，在年轻的受试者（31-65 岁）中患病率增加。在自我申报的/未治疗的高血压患者（未控制的高血压患者）或正常血压者（疑似高血压患者）和那些不知道自己血压值的患者（疑似高血压患者）中，发现高血压的比例较大。高血压患者的心血管危险因素患病率高于正常血压者。
我们的研究结果表明，社区药房的筛查是可行的，吸引了许多患者的兴趣，提高了他们对血压状况的认识。该筛查还可以发现潜在的未控制和/或疑似的新高血压患者，尤其是在年轻成年人中，以将其转介给全科医生进行确诊或进一步评估。
